Hims & Hers Health Inc. buy BTIG Research
Start price
02.02.26
/
50%
€22.89
Target price
02.02.27
€50.53
Performance (%)
12.54%
Price
28.07.26
€25.76
Summary
This prediction is currently active. The prediction currently has a performance of 12.54%. This prediction currently runs until 02.02.27. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hims & Hers Health Inc. | -10.244% | -10.244% |
| iShares Core DAX® | 1.717% | 3.368% |
| iShares Nasdaq 100 | -4.565% | -4.238% |
| iShares Nikkei 225® | -7.120% | -11.869% |
| iShares S&P 500 | -0.894% | 1.687% |
Comments by BTIG_Research for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Hims & Hers Health (NYSE:HIMS) had its price target lowered by analysts at BTIG Research from $85.00 to $60.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Stopped prediction by BTIG_Research for Hims & Hers Health Inc.
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€39.84
04.11.25
04.11.25
€73.86
04.11.26
04.11.26
-35.34%
28.07.26
28.07.26
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€26.20
07.01.25
07.01.25
€33.66
07.01.26
07.01.26
14.73%
08.01.26
08.01.26